Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Operating Expenses (2020 - 2025)

BioAtla (BCAB) has disclosed Operating Expenses for 6 consecutive years, with $11.3 million as the latest value for Q4 2025.

  • For Q4 2025, Operating Expenses fell 30.71% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $61.3 million, down 27.83%, while the annual FY2025 figure was $61.3 million, 27.83% down from the prior year.
  • Operating Expenses hit $11.3 million in Q4 2025 for BioAtla, down from $13.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $37.2 million in Q2 2023 and bottomed at $11.3 million in Q4 2025.
  • Average Operating Expenses over 5 years is $24.0 million, with a median of $24.0 million recorded in 2021.
  • Year-over-year, Operating Expenses surged 1469.03% in 2021 and then plummeted 43.08% in 2024.
  • BioAtla's Operating Expenses stood at $23.5 million in 2021, then grew by 21.59% to $28.6 million in 2022, then dropped by 0.08% to $28.5 million in 2023, then tumbled by 43.08% to $16.2 million in 2024, then plummeted by 30.71% to $11.3 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $11.3 million, $13.8 million, and $18.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.